Scientific Program

Conference Series Ltd invites all the participants across the globe to attend International Conference on Emergency & Acute Care Medicine Tokyo, Japan.

Day 2 :

Conference Series Emergency Medicine 2018 International Conference Keynote Speaker Praveen Kumar Singh  photo
Biography:

Dr. Praveen Kumar Singh has completed his BDS from Purvanchal Institute of Dental Sciences, Gorakhpur in the year 2012. In his BDS, he achieved certificate  of honor from Colgate Palmolive India Limited and a merit certificate from ISP, for securing highest marks in the subject of Periodontology. Later on, he completed his Masters training in Oral & Maxillofacial Surgery from JSS Dental College & Hospital, Mysore. Currently, he stand as Vice President of Indian Association of Dental Students an official member nation of International Association of Dental Students,Switzerland. In addition, he is also Official Student Council Member of Association of Oral & Maxillofacial Surgeons of India. He is Scientific Editor of Dental Deluge and has formerly been the Editor of the Indian Section of Dental Students Research, Switzerland. 

Abstract:

INTRODUCTION; Effective wound closure is critical for minimizing wound complications and preventing wound dehiscence. The various wound closure techniques include  staples, traditional nylon and skin sutures, subcuticular sutures and skin adhesives.  Currently topical skin adhesives are frequently being used. Most of the adhesives used are cyanoacrylates short and long chain (butyl and isobutyl cyanoacrylates)  derivatives. Cyanoacrylates (CAC) are tissue adhesives exhibiting the objectives of achieving coaptation of surgical wound borders, and thus eliciting healing. This material is bacteriostatic and biodegradable, and exhibits suitable tensile strength. 

Cyanoacrylates glue results in cutaneous closure in less than 5 minutes. It should not be used for deep wound closure or in any patient sensitive to cyanoacrylates. Wound closure using tissue adhesives require careful attention to be given to closure of subcutaneous layer to ensure optimal approximation and tension on the edges of the wound.Cyanoacrylates glue polymerise rapidly within seconds following contact with proteinaceous surfaces to form strong and flexible bonds. This chemical property makes them extensively used in different surgical application. Prior to application of cyanoacrylates, the tissue surface should be cleaned and dried as much as possible. Protection of the surrounding tissues from accidental contact with cyanoacrylates can be done by covering them by gauze, or chloramphenicol  1% ointment. 

SURGICAL TECHNIQUE; Under nasoendotracheal intubation, skin preparation was done with povidine iodine. Skin incision for each procedure was placed in the standard location. Then reduction of fracture and plating was done. In 80% of the patients subcutaneous sutures were placed. Skin closure was done with N-butyl 2 cyanoacrylate glue. Pressure dressing was placed in the usual manner for 24hrs postoperatively. 

RESULTS; In this study, REEDA Scale was used to assess healing. Redness, edema, Ecchymosis was seen in all 10 patients, which subsided by 2nd week post operatively. None of the patients had discharge from surgical site on 1st post operative day but was noted in 2 patients 1st week post operatively. There was evidence of wound gaping in 1 patient on 1st post operative day and 2 patients at end of 1st week post operatively. Stony Brook Scar evaluation was used to evaluate post operative cosmesis in this study. No significant cosmetic impairment was found in all patients at the end of the study. Patients were highly satisfied with the excellent cosmetic results.  In this study, no adverse inflammatory reactions were encountered and it is relevant to a study conducted by Ahmed Habib et al. The Surgical glue has the characteristic of being rapidly transferred from a liquid to a solid state that occurs at room temperature without the need of catalysts, solvents or application of pressure. 

CONCLUSION; The study reflects qualitative assessment of cyanoacrylates which is simple to use & with proper application resulted in uniform and everted closure of the wound. It is cost efficient as compared to other wound closure materials. The properties of cyanoacrylate glue were appreciated clinically as it showed excellent results with respect to the closure time, post operative healing and patient comfort. 

The quantitative data as reiterated from results make us conclude that cyanoacrylate glue performed excellently and showed similar cosmetic results when scarring evaluation was done. It is noteworthy that within the limitations of this study, which includes, less sample size and short duration for evaluation, this material showed excellent results and future studies in larger sample size can overcome the above stated limitations.

 

 

Keynote Forum

Mari Salminen-Tuomaala

Seinäjoki University of Applied Sciences, FINLAND

Keynote: Development of multiprofessional simulation-based education in acute care

Time : .

Conference Series Emergency Medicine 2018 International Conference Keynote Speaker Mari Salminen-Tuomaala photo
Biography:

Dr. Mari Salminen-Tuomaala, PhD in Health Sciences, is Senior Lecturer in Seinäjoki University of Applied Sciences, School of Health Care and Social Work. She is Project Manager in simulation based education research and development project. She has worked over 20 years as registered nurse at medical departments, cardiac care unit and emergency department before teaching career. Her main research and expertise areas concern acute care (intensive care, out-of-hospital emergency care, care and counseling at the emergency department), simulation based education, psychosocial coping of myocardial infarction patients and their spouses, families as clients in health care and families in challenging life situations. She has about 40 conference presentations and over 50 scientific publications.

 

 

Abstract:

Statement of the Problem: The development of multiprofessional simulation-based learning is important in acute nursing, where the sometimes rapid fluctuations in patients’ condition call for effective and competent action from those contributing to the care.  Familiarity with the competence areas and responsibilities of the other professional groups helps promote optimal action. Multiprofessional collaboration does not emergence naturally. It is a combination of many factors and requires constant and conscious development.

The purpose of the research; was to describe nursing and medical staff’s experiences of the usefulness of multiprofessional simulation-based  education in one hospital district in Finland. The research aimed at producing user-oriented knowledge to be used in the development of multiprofessional simulation pedagogical continuing education. The study is part of a larger research project, whose purpose is to build up a multiprofessional simulated learning environment for a network of partners. They involve a university of applied sciences, a vocational education centre, a health technology development center and a hospital district.

Methodology; Data were collected using a Web-based survey tool. The questionnaire contained both quantitative and qualitative items. Quantitative data was analysed using SPSS Statistics for Windows 23 and qualitative data was analysed using inductive content analysis

Findinds; Both nursing and medical staff experience that simulation education is useful for the development of multiprofessional teamwork. Members of a well-functioning multiprofessional team accept their mutual differences in competence, but work for a common goal. The collaboration can be hindered by lacking information about the other team members’ work and by different professional practices, concepts and ways of thinking.

Conclusion & Significance: Learning multiprofessional collaboration occurs both individually and in communities. Its basis lies in respecting diversity, in the potential of collaborative learning, motivation, facilitation and evaluation and in acquiring multiprofessional competence.

 

 

 

  • Emergency & Acute Care Medicine
Speaker
Biography:

Byoungseok Yoon has completed his bachelor’s degree at the age of 22 from Yonsei Unieversity, Bio-engineering department, Seoul, Korea and MD at the age of 26 years from Gachon University, School of Medicine. He is working in residency at Yonsei University, School of Medicine, Emergency Department, Severance hospital, Seoul, Korea.     
 

 

Abstract:

Many studies have reported the effectiveness of ‘time target’ on reducing emergency department (ED) overcrowding and improving clinical quality. We investigated the effect of introducing ‘time target’ on ED overcrowding and clinical quality using meta-analysis.

We searched electronic databases including PubMed, Cochrane Library and Embase until June 2017. Search keywords were including time target, national emergency access target, four hour rule, and shorter stays in ED. Two investigators selected and reviewed articles according to predefined inclusion and exclusion criteria. The quality of articles were evaluated by RoBANS checklist. Data were abstracted by a predetermined criteria and performed meta-analysis using RevMan software.

Out of 721 articles, 16 studies were included in the final analysis. A meta-analysis of four studies on ED length of stay (LOS) showed that the mean EDLOS was reduced by 0.64 hours (95% CI, 0.34~0.94) since the introduction of the “time target”. Other studies also showed that EDLOS was reduced. There was no definite trend for hospital admission rate. A meta-analysis of nine studies on the clinical quality. Showed that the total odds ratio was 1.02 (95% CI, 0.74~1.32). Time taken until the visitation of a doctor and the ainitiation of treatment were both reduced. The rate of “left without being seen” was decreased.

EDLOS was reduced and no significant association was seen between mortality and the application of ‘time target’ since the introduction of ‘time target’. “Rate of revisiting”, “time to clinician”, “time to treatment” and “rate of left without being seen” was reduced.

 

 

Speaker
Biography:

The Ebola epidemic in Western Africa (Liberia, Sierra Leone, Guinea, and Nigeria) infected tens of thousands of individuals with an approximately 60% fatality rate.  This outbreak challenged the local, regional, and national medical community to prevent a global pandemic.  The global response involving logistical, epidemiological, public health, and medical interventions slowed and eventually contained the spread.  The experiences and lessons learned awakened the global medical community to the fragility of the global health response system and provides a template from which to address future pandemics.

 

Abstract:

Description of the experience; This Ebola discussion will include lessons learned from the initial phases of engagement and global monitoring to first-hand experience as a Medical Coordinator of an Ebola Treatment Unit (ETU) in Monrovia, Liberia during the height of the outbreak to the eventual decline, and containment of the virus.  These experiences include the role of a disaster planner during the initial spread, student going through the education and training process, acting Medical Coordinator and provider in the ETU, member of the laboratory Cluster in Monrovia, and eventual trainer for local providers and other health care and public health officials.

Lessons Learned; The development and spread of the Ebola virus provides lessons learned including sending an effective public health message, how to coordinate an effective local and global response, how to manage an Ebola patient, how to run an effective and safe Ebola Treatment Unit (ETU), the complexities of coordinating a global community, and the current development and training of Rapid Response Teams.  This presentation is based on experiences that included initial protocol development, training, policy creation, and two months as Medical a Coordinator of an ETU in Monrovia, Liberia during the height and decline of the outbreak.

Learning Objectives

  1. How to send an effective public health message
  2. Coordination of local and global response resources
  3. How to manage suspected and confirmed highly infectious cases
  4. Review some of the challenges and problems identified that impacted response and care but never received public attention – i.e. the inside story.

 

 

 

 

Speaker
Biography:

Tegwen commenced as Manager, Research Support Network (RSN), Emergency Medicine Foundation (EMF), in July 2014 and is responsible for a team whose role is to expand and enhance the scope of emergency medicine research. She has over twenty-five years health research experience in Australia and Canada. She has worked across the health spectrum, including public health, health economics, health policy, health technology assessment and clinical research. She also has experience in disaster management and recovery in Australia, Canada and New Zealand, including the short and long term mental health impact of natural disasters. She is passionate about building collaborative relationships that foster interest in applicable emergency medicine research as well as helping people to develop the skills needed to address such research questions. Through such an approach, Tegwen aims to develop strong, robust and multi-disciplinary relations that can inform improve the care of patients irrespective of their geographical location.

 

Abstract:

Statement of the Problem: Conducting research in the emergency care setting is challenging. Potential issues such as acuity of potential participants, inability to obtain consent in the traditional manner, and the very nature of delivering emergency care, impact the execution of research. Research Support Networks (RSNs) offer a potential solution to overcoming barriers to emergency care-based research. Various models have been adopted across Canada, United Kingdom and the USA. Methodology & Theoretical Orientation: The Emergency Medicine Foundation (EMF) was established in 2007 to support emergency medicine research across Queensland. In 2014, EMF established the RSN in a response to a lack of capacity and research support in emergency departments.  It was devised to provide leadership, support and collaborative opportunities for emergency care research professionals. EMFs RSN model is different to networks in other countries as it operates as a hub and spoke model that facilitates multi-disciplinary collaboration and translation of knowledge to strengthen all emergency medicine care. Research Development Managers (RDMs) work across multiple Hospital and Health Services (HHSs) to expand and enhance emergency care research. All RDMs are required to capture key performance data to enable the RSN Manager to monitor increases and changes in research activities. After two full years of operation, the RSN was evaluated using an observational study of research activity metrics.  Conclusion & Significance: Through the RSN there has been an increase in emergency medicine research activity across Queensland, and not limited to those HHSs directly covered by a RDM. In total 12/16 HHS are now involved in research, either directly as the lead HHS or as a collaborating HHS. With support from the RSN, rural and remote sites that have limited exposure to research activities have become involved with projects lead by senior clinician’s at large tertiary hospitals.

 

Speaker
Biography:

I am Dr Thahseena having 2 years’ experience as a physician mainly in gynecology and infertility treatments.

 

Abstract:

Anaphylaxis is a life-threatening reaction with respiratory, cardiovascular, cutaneous or gastrointestinal manifestations resulting from exposure to an offending agent usually food, insect sting, medication or physical factors. Anaphylaxis treatment that we usually follow can be divided into 3 stage.
 
Initial Treatments;
Anaphylaxis symptoms onset varies widely, but usually occurs within seconds or minutes of exposure. In some case anaphylaxis, may be delayed for hours. Anaphylaxis can be protracted, lasting for more than 24 hours, or can reoccur after initial resolution. Initial treatment for anaphylaxis is epinephrine injection usually known as EpiPen auto injector.
 
Emergency room Management;
Administer epinephrine
Administer oxygen
Maintain airway with oropharyngeal device
Administer antihistamine
Treat hypotension with IV fluids or colloidal replacement
Treat bronchospasm preferably with beta 11 agonists given continuously or intermittently.
 
Follow Up Treatments; 
At discharge, some experts advocate a short course of antihistamines and oral corticosteroid.As anaphylaxis is a fatal condition the science is always behind to find the best treatment methods and medicines. In India, the Ayurveda medicine, one of the ancient system of medicine in the world, called PUNARNAVASAVAM is being used for similar conditions.
 
The Main Logic Behind the Use of This Medicine
This medicine is slightly alcoholic in nature and contains alcohol soluble chemical extracts of some plants. Alcohol can easily pass through the cell barriers the medicine is fast in action. The chemical nature of the drug will reduce the swelling of the airway and reduce the action of mast cells. More scientific explanation about the nature and action of the drug is unknown.
 
Main Advantages of this medicine;
Although the EpiPen is the immediate choice of medicine to save life of the patient we need supportive treatments like emergency room treatment and in many cases, follow up treatment also to make the patient to be normal. If those can be done with this single medicine it will be a great choice.
 
CLINICAL EXPERIENCE;
1. The case was for a child of 1 1/2 years old, had a history of food allergy to multiple items like, milk nuts, soy etc.
• The child drank some milk, after 5 minutes the symptoms appeared
• The skin Started having urticaria, itching over face, arms and some parts of chest
• The respiratory symptoms include difficulty in breathing, coughing, noise while breathing
Given Punarnavasam 1 ml, orally in 15 minutes’ interval for 4 times. After 2 dose, itself the child got ease in breathing. After one hour, the child became normal with normal respiration, all the skin manifestations are gone and started playing actively
2. The second was a girl child of age 2 years, had a history of severe allergy towards nuts
• She accidently took a very small piece of hazelnut along with her non-allergic sibling.
• She did not develop any symptoms until 4hours after the intake of nut.
• Then she started coughing vigorously, voice became so bad, eyes become protruded resulting in severe respiratory obstruction. She was trying to take breath through mouth, but it was difficult for her
• No skin manifestations were there.
Gave Punarnavasam 2 ml orally in 10 minutes’ interval for 6 times and then in 15 minutes’ interval for 4 times. After 30 minutes the symptoms got reduced and she started breathing through nose, cough reduced. After 2 hours, she became normal all symptoms got relieved.

  • Anaphylaxis

Session Introduction

Thahseena Pokker

Emergency Physician in USA

Title: A different approach to anaphylaxis treatment
Speaker
Biography:

I am Dr Thahseena having 2 years’ experience as a physician mainly in gynecology and infertility treatments.

 

Abstract:

Anaphylaxis is a life-threatening reaction with respiratory, cardiovascular, cutaneous or gastrointestinal manifestations resulting from exposure to an offending agent usually food, insect sting, medication or physical factors. Anaphylaxis treatment that we usually follow can be divided into 3 stages;

Initial Treatments; Anaphylaxis symptoms onset varies widely, but usually occurs within seconds or minutes of exposure. In some case anaphylaxis, may be delayed for hours. Anaphylaxis can be protracted, lasting for more than 24 hours, or can reoccur after initial resolution. Initial treatment for anaphylaxis is epinephrine injection usually known as EpiPen auto injector.

  • Emergency room Management;
  • Administer epinephrine
  • Administer oxygen
  • Maintain airway with oropharyngeal device
  • Administer antihistamine
  • Treat hypotension with IV fluids or colloidal replacement

Treat bronchospasm preferably with beta 11 agonists given continuously or intermittently

Follow Up Treatments; At discharge, some experts advocate a short course of antihistamines and oral corticosteroid. As anaphylaxis is a fatal condition the science is always behind to find the best treatment methods and medicines. In India, the Ayurveda medicine, one of the ancient system of medicine in the world, called PUNARNAVASAVAM is being used for similar conditions.

The Main Logic Behind the Use of This Medicine; This medicine is slightly alcoholic in nature and contains alcohol soluble chemical extracts of some plants. Alcohol can easily pass through the cell barriers the medicine is fast in action. The chemical nature of the drug will reduce the swelling of the airway and reduce the action of mast cells. More scientific explanation about the nature and action of the drug is unknown.

Main Advantages of this medicine; Although the EpiPen is the immediate choice of medicine to save life of the patient we need supportive treatments like emergency room treatment and in many cases, follow up treatment also to make the patient to be normal. If those can be done with this single medicine, it will be a great choice.

CLINICAL EXPERIENCE

1. The case was for a child of 1 1/2 years old, had a history of food allergy to multiple items like, milk nuts, soy etc.

  •  The child drank some milk, after 5 minutes the symptoms appeared
  •  The skin Started having urticaria, itching over face, arms and some parts of chest
  •  The respiratory symptoms include difficulty in breathing, coughing, noise while breathing

Given Punarnavasam 1 ml, orally in 15 minutes’ interval for 4 times. After 2 dose, itself the child got ease in breathing. After one hour, the child became normal with normal respiration, all the skin manifestations are gone and started playing actively

2. The second was a girl child of age 2 years, had a history of severe allergy towards nuts

  • She accidently took a very small piece of hazelnut along with her non-allergic sibling.
  • She did not develop any symptoms until 4hours after the intake of nut.
  • Then she started coughing vigorously, voice became so bad, eyes become protruded resulting in severe respiratory obstruction. She was trying to take breath through mouth, but it was difficult for her
  •  No skin manifestations were there.

Gave Punarnavasam 2 ml orally in 10 minutes’ interval for 6 times and then in 15 minutes’ interval for 4 times. After 30 minutes the symptoms got reduced and she started breathing through nose, cough reduced. After 2 hours, she became normal all symptoms got relieved.